Day: July 19, 2023

BOCA RATON, Fla., July 19, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases, today announced the pricing of a public offering of 3,285,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 6,570,000 shares of its common stock at a combined public offering price $0.64 per share (or pre-funded warrant in lieu thereof) and associated warrants. Each share of common stock (or prefunded warrant in lieu thereof) is being sold together with two warrants, each to purchase one share of common stock. The warrants will have an exercise price of $0.64 per share, are exercisable immediately...

Yulho investing $5 million to accelerate Aqua Metals in the US, licensing low-carbon battery recycling technology for expansion in Asia and the EU RENO, Nev., July 19, 2023 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), a pioneer in sustainable lithium-ion battery recycling, today announced it has entered into a strategic partnership with Yulho Co., Ltd. (“Yulho”), an innovative storage solution and battery materials company based in South Korea. By aligning global partnerships and shared expertise, Aqua Metals and Yulho aim to drive innovation in lithium battery recycling and set a new standard for a low-carbon, circular supply of the critical minerals that power an electrified future. Initiating the partnership, Yulho will make a strategic equity investment of $5 million in Aqua Metals,...

NORCROSS, Ga., July 19, 2023 (GLOBE NEWSWIRE) — CoreCard Corporation (NYSE: CCRD), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, intends to hold an investor conference call on August 2, 2023, at 11:00 A.M. Eastern Time in conjunction with the company’s earnings release for the quarter ended June 30, 2023. The company plans to issue a press release with the financial results for the period before the market opens on August 2, 2023. Interested investors are invited to attend the conference call by accessing the webcast at https://www.webcast-eqs.com/register/corecard080223/en or by dialing 1-877-407-0890. As part of the conference call CoreCard will be conducting a question-and-answer session where participants are invited to email their questions...

Dragonfly Energy has begun successfully dry depositing anode electrodes using its patented battery manufacturing processes This crucial step deploys patented Dragonfly Energy technology and proves the proprietary processes work at scale, paving a path forward for domestic manufacturing of lithium batteries The patented processes operate within a significantly smaller manufacturing footprint and are chemistry agnostic, allowing for potential wide market expansion by the Company Dragonfly Energy expects to begin cathode production in the third quarter of 2023, with full cells coming off the pilot line by the end of 2023 The pilot line is capable of domestically producing up to 150MWh of LiFePO4 battery cells annually, and production is scalable with additional production linesRENO, Nev., July 19, 2023 (GLOBE NEWSWIRE) — Dragonfly...

ANN ARBOR, Mich., July 19, 2023 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces today that it has filled two key researcher positions. These new hires hit the ground running with nearly 50 years of combined sericulture experience. The new staff members have been integrated into roles at the intersection of R&D and production to strengthen the transition of new technologies from the lab to the field. The new staff has introduced new egg treatment/hatching protocol systems that could reduce the rearing cycle by up to 40% during scale-up. Once proven, this approach may allow the Company to accelerate the delivery of its four-strain “double hybrid”...

Partnership allows commercial biopharma companies to leverage real-time data within comprehensive Prognos Marketplace to provide available treatment options for patients NEW YORK and STAMFORD, Conn., July 19, 2023 (GLOBE NEWSWIRE) — GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, and Prognos Health, the largest real-world integrated data marketplace, today announced a strategic partnership to shorten the treatment odyssey for rare disease patients via real world data. The partnership offers life science companies a comprehensive de-identified dataset specific to rare disease to accelerate access to life saving therapies. Through this partnership, the Prognos Marketplace will integrate GeneDx’s de-identified rare disease data, including regularly updated data as GeneDx continues to...